Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Board Changes

9 Jul 2020 14:28

RNS Number : 5819S
B&M European Value Retail S.A.
09 July 2020
 

 

 

9 July 2020 

B&M European Value Retail S.A.

Board Changes

 

B&M European Value Retail S.A. (the "Company") announces that, further to the announcement made on 3 March 2020, Alex Russo will join the Company as the Chief Financial Officer ("CFO") Designate on 5 October 2020. Alex will be appointed as an Executive Director and Chief Financial Officer ("CFO") of the Company on 16 November 2020 following a handover period with Paul McDonald.

 

Paul McDonald will retire from the Board of Directors of the Company on 15 November 2020 but will remain employed by the Company under garden leave and remain able to assist the group as required for the remainder of his notice period to 8 January 2021.

 

Peter Bamford, Chairman, said:

 "I am delighted that Alex Russo will be joining the Board of B&M later this year. His previous roles with leading retail businesses in the UK and internationally brings a valuable level of experience to the Board as our business continues to grow at a significant rate. Paul McDonald has done an excellent job as CFO for the last nine years and we thank him for his contribution and wish him well for the future."

 

In respect of Paul McDonald's remuneration the Company confirms that the following financial terms below have been agreed with Paul in line with the Company's Remuneration Policy which was approved by the shareholders at the 2018 AGM:

 

1. he will continue to receive salary and benefits up to the expiry of his notice period to 8 January 2021;

 

2. he will participate in the 2020/21 annual incentive bonus plan ("AIP"), on a pro-rata basis (excluding the period of garden leave), subject to the determination by the Remuneration Committee of the outcome of the performance conditions following the financial year end. One-third of any bonus will be subject to deferral into shares in the normal way;

 

3. as a good leaver his outstanding awards under the Long Term Incentive Plan ("LTIP") made in 2018 and 2019 will vest to the extent that the performance conditions are met, pro-rated proportionately to his actual period of service (excluding the period of garden leave);

 

4. LTIP awards in respect of which the performance conditions have already been satisfied, which were made in 2015, 2016 and 2017, will be exercisable by him when the holding periods for those awards have expired;

 

5. his Deferred Bonus Share Plan ("DBSP") awards (including any to be awarded on the outturn of the 2020/21 AIP bonus) will vest and become exercisable on the expiry of the normal vesting periods in relation to those awards; and

 

6. he will not receive an LTIP grant in 2020/21 and no compensation for loss of office will be payable.

 

All AIP, LTIP or DBSP awards which include malus and clawback provisions under their respective plan rules will continue to apply.

 

Details of Paul McDonald's remuneration will be disclosed in the Directors' Remuneration Report for 2020/21 and the vesting of share awards in subsequent years as applicable.

 

Enquiries

B&M European Value Retail S.A.

For further information please contact +44 (0) 151 728 5400

Simon Arora, Chief Executive Officer

Steve Webb, Investor Relations Director

Investor.relations@bandmretail.com

 

Media

For media please contact +44 (0) 207 379 5151

Maitland

Daniel Yea

bmstores-maitland@maitland.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABXGDRLDGDGGC
Date   Source Headline
14th Nov 20235:52 pmRNSPricing of £250 Million Senior Secured Notes
13th Nov 20232:28 pmRNSPre Stabilisation Notice
13th Nov 20239:39 amRNS£250 Million Senior Secured Notes Offering
13th Nov 20239:30 amRNSTender Offer
13th Nov 20239:27 amRNS£250 Million Senior Secured Notes Offering
13th Nov 20239:07 amRNS£250 Million Senior Secured Notes Offering
9th Nov 20237:00 amRNSFY24 Interim Results
3rd Oct 20237:25 amRNSTotal Voting Rights
22nd Sep 202311:33 amRNSDirector Appointment and Results of OGM
19th Sep 20238:50 amRNSTiming of announcement of Half Year Results
7th Sep 20232:19 pmRNSNotification of major holdings
7th Sep 20231:31 pmRNSDirector/PDMR Shareholding
5th Sep 20239:48 amRNSAcquisition of Assets from Wilko Ltd (in admin)
1st Sep 202310:30 amRNSTotal Voting Rights
1st Sep 202310:00 amRNSDirector/PDMR Shareholding
14th Aug 20239:08 amRNSNotice of Ordinary General Meeting- replace
14th Aug 20237:00 amRNSNotice of Ordinary General Meeting
9th Aug 20234:02 pmRNSGrant of share options to PDMR
2nd Aug 20239:21 amRNSGrant of options to senior managers
2nd Aug 20239:18 amRNSGrant of options to Directors
28th Jul 20237:00 amRNSGroup Trading Director Retention Agreement
27th Jul 20231:42 pmRNSTR-1 Correction Announcement
26th Jul 20234:15 pmRNSTR-1 Notification of major holdings
26th Jul 20233:33 pmRNSBoard change
26th Jul 20238:45 amRNSEGM Voting results announcement
26th Jul 20238:15 amRNSAGM 2023 Voting results announcement
18th Jul 202311:00 amRNSBlock Listing Application
13th Jul 20231:46 pmRNSBlock listing Interim Review
30th Jun 20239:00 amRNSTotal Voting Rights
29th Jun 20237:00 amRNSQ1 FY24 Trading update
20th Jun 202310:01 amRNSBoard Appointment
20th Jun 20238:30 amRNSNotice of FY24 First Quarter Trading Statement
19th Jun 20237:00 amRNSAnnual Financial Report and Notices of AGM and EGM
13th Jun 20234:03 pmRNSDirector/PDMR Shareholding
31st May 20237:05 amRNSRetirement of Director after AGM
31st May 20237:00 amRNSFY23 Preliminary Results
22nd May 20236:08 pmRNSTR1- Notification of major holdings
21st Apr 202310:35 amRNSBoard Change
17th Apr 20234:28 pmRNSTiming of Preliminary Results Announcement
3rd Apr 20233:00 pmRNSNotice to Noteholders
3rd Apr 20232:59 pmRNSBank Facility Extension
16th Feb 20235:37 pmRNSPDMR Share Purchase
13th Jan 20231:09 pmRNSBlock listing Interim Review
11th Jan 20233:46 pmRNSDirector Dealing: Purchase of Bonds
10th Jan 20233:23 pmRNSDirector/PDMR Shareholding
5th Jan 20237:00 amRNSStrong Q3 FY23 Trading
14th Dec 20221:59 pmRNSDirector Dealing: Purchase of Bonds
9th Dec 202211:43 amRNSNotice of FY23 Third Quarter Trading Statement
18th Nov 20229:14 amRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.